Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
SPATIAL TRANSCRIPTOMICS IDENTIFIES SPARC AS A PROGNOSTIC BIOMARKER IN UNCLASSIFIABLE INTERSTITIAL LUNG DISEASES — Takayuki Niitsu (2025) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
SPATIAL TRANSCRIPTOMICS IDENTIFIES SPARC AS A PROGNOSTIC BIOMARKER IN UNCLASSIFIABLE INTERSTITIAL LUNG DISEASES
Shared by
Akira Shizuo
Osaka University
SPATIAL TRANSCRIPTOMICS IDENTIFIES SPARC AS A PROGNOSTIC BIOMARKER IN UNCLASSIFIABLE INTERSTITIAL LUNG DISEASES
Article
2025
en
Authors
+11 more
TN
Takayuki Niitsu
TK
Toshiaki Kataoka
KF
Kiyoharu Fukushima
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2025
Spatial transcriptomics identifies <scp>SPARC</scp> as a prognostic marker in interstitial lung diseases
Takayuki Niitsu
,
Toshiaki Kataoka
,
Kiyoharu Fukushima
,
Daisuke Motooka
,
Shigeyuki Shichino
,
Yayoi Natsume‐Kitatani
,
Hideya Kitamura
,
Takashi Niwa
,
Tomohisa Baba
,
Daisuke Okuzaki
,
Atsushi Kumanogoh
,
Akira Shizuo
,
Koji Okudela
,
Takashi Ogura
Article
1998
8-Isoprostane as a Biomarker of Oxidative Stress in Interstitial Lung Diseases
Paolo Montuschi
,
GIOVANNI CIABAT TONI
,
Paolo Paredi
,
Panagiotis Pantelidis
,
Roland M. du Bois
,
Sergei A. Kharitonov
,
Peter J Barnes
Article
2011
Interstitial lung diseases in a lung cancer screening trial
Nicola Sverzellati
,
L. Guerci
,
G. Randi
,
Elisa Calabrò
,
Carlo La Vecchia
,
Alfonso Marchianò
,
Alberto Pesci
,
Maurizio Zompatori
,
Ugo Pastorino
Article
2012
suPAR as a prognostic biomarker in sepsis
Katia Donadello
,
Sabino Scolletta
,
Cecilia Covajes
,
Jean Louis Vincent
Article
2025
CBFA2T3 as a Key Prognostic Biomarker in Lung Adenocarcinoma: Insights from Comprehensive Analysis and Validation
Jianbo Xiao
,
Kexin Luo
,
Meihan Liu
,
Haiyang Zhao
,
Yuanze Cai
,
Yan Gui
,
Hongpan Zhang
.jpg){kind=small}
Discussion(0)
No comments yet. Be the first to comment.